Authors
Latest:
Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhalThe expert panel shares clinical pearls for treatment and management of Spinal Muscular Atrophy. O painel de especialistas compartilha recomendações valiosas para o tratamento e manejo da atrofia muscular espinhal.
Latest:
Stanford Children’s Health: A Comprehensive Approach to Care for a Child With a Neurological ConditionPhysicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.
Latest:
Uncovering New, Synergistic Ways to Treat Tuberous Sclerosis Complex: Darcy Krueger, MD, PhDThe director of the Tuberous Sclerosis Clinic at Cincinnati Children’s provided insight on whether the timing and combination of certain therapeutics may impact the long-term care for patients with tuberous sclerosis complex. [WATCH TIME: 3 minutes]
Latest:
Understanding the Association Between Obstructive Sleep Apnea Treatment and Dementia Risk: Galit L. Dunietz, PhD, MPHThe assistant professor of neurology at the University of Michigan provided context on a previous study which suggested that treatment of obstructive sleep apnea may reduce the risk of subsequent dementia. [WATCH TIME: 3 minutes]
Latest:
Dedicated Efforts for Improving Sleep Quality in Pediatrics, Adolescents: Sarah Honaker, PhD; Maureen McQuillan, PhDThe duo from Indiana University School of Medicine discussed the ongoing research initiatives to better understand sleep disorders among pediatrics, and ways to improve approaches like cognitive behavioral therapy. [WATCH TIME: 4 minutes]
Latest:
Expanding the Understanding of ALS With New Methods: Brian Wainger, MD, PhDThe assistant professor of neurology and anesthesiology at Harvard Medical School discussed non-traditional ways ALS research is changing and where the focus should continue to be.
Latest:
A Comprehensive Analysis of Stroke Prevalence Among Adults in the United States: Wells Andres, MDThe neurology resident from the University of Pennslyvania talked about stroke prevalence in the United States between 1999 and 2018 as part of a presentation at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Latest:
Targeting Neuroinflammation as a Novel Approach in Brain Health for Alzheimer Disease: RJ Tesi, MDThe chief executive officer at INmune Bio discussed a unique approach from a phase 1 study targeting neuroinflammation in the brain to improve cognitive abilities and maintain memory. [WATCH TIME: 5 minutes]
Latest:
Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhDThe clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]
Latest:
The Quick Neurologic Examination Tool in the PICU: Apirada Thongsing, MDThe resident physician at Montefiore Medical Center shared her experience with the novel and standardized quick examination tool and the data presented at AAN 2022. [WATCH TIME: 3 minutes]
Latest:
Navigating the Cognitive Screening Toolbox: Dustin Hammers, PhDThe associate professor of neurology at the Indiana University School of Medicine discussed the screening paradigm for Alzheimer disease, and the reluctancy to use new digital tools over traditional methods. [WATCH TIME: 6 minutes]
Latest:
Quality of Life Improvements in MS Following Wellness Program: Brian Hutchinson, PT, MSCSThe director of the Multiple Sclerosis Achievement Center in Sacramento discussed 3-year data from an assessment of the program, outlining key findings and future research efforts. [WATCH TIME: 6 minutes]
Latest:
Migraine Management During Pregnancy, Women’s Healthcare Providers vs. Headache Specialists: Stephanie Bakaysa, MDThe maternal fetal medicine specialist at Hartford HealthCare Medical Group talked about the challenges of prescribing migraine treatment during pregnancy. [WATCH TIME: 4 minutes]
Latest:
AUPN Leadership Minute Episode 34: External PartnershipsEpisode 34 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Merit Cudkowicz, MD, of Mass General Hospital and Harvard Medical School. [WATCH TIME: 4 minutes]
Latest:
Unmet Needs and Improving Diagnosis of Dyskinesia in Parkinson DiseaseThe expert panel reviews unmet needs in treatment and management of dyskinesia and shares advice for physicians treating patients with Parkinson disease.
Latest:
Challenges of Targeting Cytokines in MS: Stephanie Blandford, MScThe PhD candidate at the neuroimmunology laboratory at Memorial University of Newfoundland discussed the potential of interleukin-1 receptor antagonist as a biomarker in MS disability as well as a therapeutic target.
Latest:
Health Disparities and Equities in the Multiple Sclerosis Latinx Community: Farren B. S. Briggs, PhD, ScMThe associate professor in the department of population and quantitative health sciences at Case Western Reserve University School of Medicine talked about striving to understand and address the disparities among Latinx patients with multiple sclerosis. [WATCH TIME: 2 minutes]
Latest:
Effect of Social Determinants of Health on Brain Aging in Minoritized Patients with Multiple Sclerosis: Cristina A.F. Román, PhDThe National Multiple Sclerosis Society sponsored research fellow at Kessler Foundation talked about a research project that investigates the differences in brain structure and aging metrics among patients with multiple sclerosis from differing racial and ethnic backgrounds. [WATCH TIME: 5 minutes]
Latest:
Further Advancing the Treatment and Research Field for Restless Legs Syndrome: John Winkelman, MD, PhDThe chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital provided perspective on the current major research priorities for the treatment of restless legs syndrome. [WATCH TIME: 3 minutes]
Latest:
Addressing Unmet Needs in Narcolepsy Management: Practical Insight for Community-Based PhysiciansClosing out his discussion on narcolepsy management, Chris Winter, MD, highlights current unmet needs and shares practical advice for community physicians.
Latest:
James Grotta, MD: The Future of Stroke Care Going into 2021The vascular neurologist at Memorial Hermann Medical Group explained how clinical stroke care will change in 2021 amid the COVID-19 pandemic.
Latest:
Pregnancy in MS PatientsElisabeth Lucassen, MD, provides an overview of the impact of pregnancy in multiple sclerosis (MS) patients, the management of MS and pregnancy, and the use of disease-modifying therapies in pregnancy and breastfeeding.
Latest:
Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhDThe expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]
Latest:
AUPN Leadership Minute Episode 14: Challenges of Virtual Residency InterviewsEpisode 14 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Nina Browner, MD, of University of North Carolina School of Medicine. [WATCH TIME: 5 minutes]
Latest:
The Ever-Expanding Multiple Sclerosis TherapeuticsJoin Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
Latest:
AUPN Leadership Minute Episode 35: Building a High-Quality QI ProgramEpisode 35 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Carl Gold, MD, MS, of Stanford University. [WATCH TIME: 5 minutes]
Latest:
Emerging Therapies and Unmet Needs in MSDrs Ahmed Zayed and Mark S. Freedman review emerging therapies in the pipeline and unmet needs in the multiple sclerosis treatment landscape, as well as take-home thoughts.
Latest:
Positive Impact of Ataluren on Walking Ability in Duchenne Muscular Dystrophy: Jeffrey M. Statland, MDAt the 2023 AAN Annual Meeting, the neuromuscular disease specialist and professor of neurology at the University of Kansas Medical Center talked about the phase 3 study investigating ataluren for Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]
